Rubius Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rubius Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2022.
  • Rubius Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $263M, a 27.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $263M +$56.7M +27.4% Dec 31, 2022 10-K 2023-02-27
Q4 2021 $207M +$66.8M +47.8% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $140M +$54M +62.9% Dec 31, 2020 10-K 2023-02-27
Q4 2019 $85.9M +$52.2M +155% Dec 31, 2019 10-K 2023-02-27
Q4 2018 $33.7M +$21.1M +168% Dec 31, 2018 10-K 2022-02-25
Q4 2017 $12.6M +$6.12M +94.8% Dec 31, 2017 10-K 2021-02-23
Q4 2016 $6.45M Dec 31, 2016 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.